EP3248610
FGF21 STÖKKBRIGÐI OG NOTKUN ÞEIRRA
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
4.5.2010EP published:
20.12.2023EP application number:
17167682.8
EP translation filed:
16.1.2024Grant published:
15.2.2024EPO information:
European Patent Register
Max expiry date:
3.5.2030Expiry date:
3.5.2026Next due date:
31.5.2026
Title in English:
FGF21 MUTANTS AND USES THEREOFLanguage of the patent:
English
Timeline
Today
4.5.2010EP application
20.12.2023EP Publication
16.1.2024Translation submitted
15.2.2024Registration published
3.5.2026Expires
Owner
Name:
Amgen Inc.Address:
One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US
Inventor
Name:
BELOUSKI, Edward JohnAddress:
Thousand Oaks, CA 91360, US
Name:
ELLISON, Murielle MarieAddress:
Thousand Oaks, CA 91360, US
Name:
HAMBURGER, Agnes EvaAddress:
Thousand Oaks, CA 91320, US
Name:
HECHT, Randy IraAddress:
Raleight, NC 27612, US
Name:
LI, Yue-ShengAddress:
Cambridge, MA 02141, US
Name:
MICHAELS, Mark LeoAddress:
Encino, CA 91316, US
Name:
SUN, JeonghoonAddress:
San Diego, CA 92116, US
Name:
XU, JingAddress:
Cambridge, MA 02141, US
Agent
Name:
Konstantina KoriatopoulouAddress:
1443 3rd September str., GR
Priority
Number:
175736 PDate:
5.5.2009Country:
US
Number:
285118 PDate:
9.12.2009Country:
US
Classification
Categories:
A61K 38/18, C07K 14/50, A61K 38/00
Annual fees
Number
Paid
Expires
Payer
Number: 15
Paid: 5.4.2024
Expires: 3.5.2025
Payer: Árnason Faktor ehf.
Number: 16
Paid: 29.4.2025
Expires: 3.5.2026
Payer: Árnason Faktor ehf.